Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report)’s share price traded up 12.5% during mid-day trading on Monday . The company traded as high as $2.45 and last traded at $2.25. 3,777 shares were traded during trading, an increase of 164% from the average session volume of 1,433 shares. The stock had previously closed at $2.00.
Silence Therapeutics Stock Performance
The company’s 50-day moving average price is $4.33 and its 200 day moving average price is $5.84.
Silence Therapeutics Company Profile
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
Read More
- Five stocks we like better than Silence Therapeutics
- Stock Average Calculator
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- What is a support level?
- 2 Drone Stocks Surging from Increased Media Attention
- Options Trading – Understanding Strike Price
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
